• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多糖、肠道微生物群与人类健康关系的研究综述。

Review of the relationships among polysaccharides, gut microbiota, and human health.

机构信息

State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China.

Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.

出版信息

Food Res Int. 2021 Feb;140:109858. doi: 10.1016/j.foodres.2020.109858. Epub 2020 Nov 2.

DOI:10.1016/j.foodres.2020.109858
PMID:33648176
Abstract

As a complex ecosystem of the human body, the intestinal flora maintains a dynamic balance with the host and plays an irreplaceable role in life activities such as nutritional metabolism and host immunity. The intestinal flora interacts with polysaccharides, the intestinal flora digests non-digestible polysaccharides, and polysaccharides can be used as an important energy source for intestinal microorganisms. Disturbance of the gut microbiota (GM) leads to the occurrence of diseases, polysaccharides as prebiotics can improve the disease by regulating the composition of GM. In this paper, we reviewed the current knowledge about the relationship between polysaccharides, gut microbiota, and and human health, described the microbial composition of the human, the relationship between intestinal flora disorders and disease occurrence, and summarized the interactions between polysaccharides and intestinal microorganisms.

摘要

作为人体的一个复杂生态系统,肠道菌群与宿主保持着动态平衡,在营养代谢和宿主免疫等生命活动中发挥着不可替代的作用。肠道菌群与多糖相互作用,肠道菌群消化不可消化的多糖,而多糖可以作为肠道微生物的重要能量来源。肠道微生物群(GM)的紊乱会导致疾病的发生,多糖作为益生元可以通过调节 GM 的组成来改善疾病。本文综述了多糖、肠道菌群与人体健康之间关系的最新知识,描述了人体的微生物组成、肠道菌群紊乱与疾病发生的关系,并总结了多糖与肠道微生物之间的相互作用。

相似文献

1
Review of the relationships among polysaccharides, gut microbiota, and human health.多糖、肠道微生物群与人类健康关系的研究综述。
Food Res Int. 2021 Feb;140:109858. doi: 10.1016/j.foodres.2020.109858. Epub 2020 Nov 2.
2
Prebiotics and the Human Gut Microbiota: From Breakdown Mechanisms to the Impact on Metabolic Health.益生元和人类肠道微生物群:从分解机制到对代谢健康的影响。
Nutrients. 2022 May 17;14(10):2096. doi: 10.3390/nu14102096.
3
Gut microbiota fermentation of marine polysaccharides and its effects on intestinal ecology: An overview.海洋多糖的肠道微生物发酵及其对肠道生态的影响:概述。
Carbohydr Polym. 2018 Jan 1;179:173-185. doi: 10.1016/j.carbpol.2017.09.059. Epub 2017 Sep 19.
4
Pectic polysaccharides: Targeting gut microbiota in obesity and intestinal health.果胶多糖:靶向肥胖和肠道健康中的肠道微生物群。
Carbohydr Polym. 2022 Jul 1;287:119363. doi: 10.1016/j.carbpol.2022.119363. Epub 2022 Mar 18.
5
The Effect of Natural Soluble Polysaccharides on the Type 2 Diabetes through Modulating Gut Microbiota: A Review.天然可溶性多糖通过调节肠道菌群对 2 型糖尿病的影响:综述。
Curr Med Chem. 2021;28(26):5368-5385. doi: 10.2174/0929867328666210309110352.
6
Edible fungal polysaccharides, the gut microbiota, and host health.食用真菌多糖、肠道微生物群与宿主健康。
Carbohydr Polym. 2021 Dec 1;273:118558. doi: 10.1016/j.carbpol.2021.118558. Epub 2021 Aug 14.
7
The Role of Prebiotics in Modulating Gut Microbiota: Implications for Human Health.益生菌在调节肠道菌群中的作用:对人类健康的影响。
Int J Mol Sci. 2024 Apr 29;25(9):4834. doi: 10.3390/ijms25094834.
8
Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review.多糖与肠道微生物群相互作用:代谢组学和微生物综述。
Food Res Int. 2022 Oct;160:111653. doi: 10.1016/j.foodres.2022.111653. Epub 2022 Jul 10.
9
Molecular Mechanism of Polysaccharides Extracted from Chinese Medicine Targeting Gut Microbiota for Promoting Health.中药多糖通过靶向肠道微生物群促进健康的分子机制。
Chin J Integr Med. 2024 Feb;30(2):171-180. doi: 10.1007/s11655-022-3522-y. Epub 2022 May 18.
10
Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review.植物、海藻和食用菌多糖对肠道微生物群的调节作用及相关健康益处:综述
Int J Biol Macromol. 2022 Apr 15;204:169-192. doi: 10.1016/j.ijbiomac.2022.01.166. Epub 2022 Feb 2.

引用本文的文献

1
Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications.肠道微生物群与代谢产物:糖尿病及其并发症的生物标志物和治疗靶点
Nutrients. 2025 Aug 11;17(16):2603. doi: 10.3390/nu17162603.
2
Natural polysaccharides with the reduction of intestinal barrier damage in cardiovascular diseases.具有减轻心血管疾病中肠道屏障损伤作用的天然多糖。
Mol Cell Biochem. 2025 Jul 13. doi: 10.1007/s11010-025-05352-6.
3
Probiotics and prebiotics in the treatment of functional constipation in the elderly individuals.
益生菌和益生元治疗老年功能性便秘
World J Gastrointest Pharmacol Ther. 2025 Jun 5;16(2):105242. doi: 10.4292/wjgpt.v16.i2.105242.
4
Variations in Intestinal Microbiota Among Three Species in the Cervidae Family Under the Same Feeding Conditions.相同饲养条件下鹿科三种动物肠道微生物群的差异
Vet Sci. 2025 May 3;12(5):438. doi: 10.3390/vetsci12050438.
5
Advances in the study of Ophiopogon japonicus polysaccharides: structural characterization, bioactivity and gut microbiota modulation regulation.麦冬多糖的研究进展:结构表征、生物活性及对肠道微生物群的调节作用
Front Pharmacol. 2025 May 2;16:1583711. doi: 10.3389/fphar.2025.1583711. eCollection 2025.
6
Fermentation of Alginate and Its Oligosaccharides by the Human Gut Microbiota: Structure-Property Relationships and New Findings Focusing on .人体肠道微生物群对藻酸盐及其寡糖的发酵:结构-性质关系及聚焦于……的新发现
Nutrients. 2025 Apr 24;17(9):1424. doi: 10.3390/nu17091424.
7
Therapeutic Prospects of Polysaccharides: Extraction, Purification, and Functional Activity.多糖的治疗前景:提取、纯化及功能活性
Mar Drugs. 2025 Apr 8;23(4):163. doi: 10.3390/md23040163.
8
A Comprehensive, Analytical Narrative Review of Polysaccharides from the Red Seaweed : Pharmaceutical Applications and Mechanistic Insights for Human Health.红海藻类多糖的综合分析性叙述性综述:药物应用及对人类健康的作用机制洞察
Nutrients. 2025 Feb 20;17(5):744. doi: 10.3390/nu17050744.
9
Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer.结直肠癌中肠道微生物群与脂肪酸代谢之间的相互作用
Cell Death Discov. 2025 Feb 26;11(1):78. doi: 10.1038/s41420-025-02364-5.
10
Classification of Nanomaterial Drug Delivery Systems for Inflammatory Bowel Disease.用于炎症性肠病的纳米材料药物递送系统分类
Int J Nanomedicine. 2025 Feb 3;20:1383-1399. doi: 10.2147/IJN.S502546. eCollection 2025.